Innovating Works

H2020

Cerrada
HORIZON-HLTH-2021-DISEASE-04-01
Improved supportive, palliative, survivorship and end-of-life care of cancer patients
ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:
Sólo fondo perdido 100%
Europeo
Mostrando 21 al 40 de 49 resultados
EU NAVIGATE: Implementation and evaluation of a Navigation Intervention for People with Cancer in Old Age and the... VRIJE UNIVERSITEIT BRUSSEL tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Background: Most people who have cancer are older people, affecting millions of Europeans each year. Providing high-quality, equitable, and...
2022-05-24 - 2027-08-31 | Financiado
LiverTarget: Next generation advanced RNA inhibition therapy to treat cardiometabolic disease TAMPEREEN KORKEAKOULUSAATIO SR tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 RNA Therapeutics comprise a new rapidly expanding category of drugs including small interfering RNAs (siRNA) and messenger RNAs (mRNA) that...
2022-05-24 - 2027-04-30 | Financiado
INSPIRE: Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delive... MYRIAD CONSULTING LIMITED tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 Lung cancer (LC) treatments have advanced in recent years with the advent of genetic profiling and immunotherapy. However, LC is a complex h...
2022-05-24 - 2025-05-31 | Financiado
geneTIGA: Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome edit... CHARITE UNIVERSITAETSMEDIZIN BERLIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 "There is an increasing prevalence of chronic diseases caused by undesired immune reactions (>10%) with high burden for the both patients (c...
2022-05-23 - 2026-06-30 | Financiado
Long Covid: Decision support for prediction and management of Long Covid Syndrome (LCS) HUSYHTYMA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 We will develop tools and knowledge to support physicians in accurately managing Long COVID syndrome (LCS) which has a significant impact on...
2022-05-23 - 2026-05-31 | Financiado
HEAL: HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to... MEDIZINISCHE HOCHSCHULE HANNOVER tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 HEAL will focus on general bottlenecks to induced pluripotent stem cell therapies with a particular focus on heart failure, which remains a...
2022-05-23 - 2026-02-28 | Financiado
EPIVINF: Epigenetic regulation of host factors in viral infections EPIVINF FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 The EPIVINF project aims to gain a deep understanding of how acute viral infections alter the epigenetic regulation of host factors that are...
2022-05-23 - 2027-08-31 | Financiado
VECTOR: Vectors to Accessible Critical Raw Material Resources in Sedimentary Basins HELMHOLTZZENTRUM DRESDENROSSENDORF EV tramitó un HORIZON EUROPE: HORIZON-CL4-2021-RESILIENCE-01 The EU imports 80% of its industrial raw materials making European supply chains highly vulnerable to disruption and threatening the EU's ab...
2022-05-22 - 2025-05-31 | Financiado
PAINLESS: Pain relief in palliative care of cancer using home based neuromodulation and predictive biomarkers UNIVERSIDAD DE SANTIAGO DE COMPOSTELA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 More than 50% of cancer patients develop pain before death: 80% can be treated with drugs, but 20% show a low response or have serious adver...
2022-05-20 - 2027-05-31 | Financiado
NEUROCOV: The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV BUNDESMINISTERIUM FUER GESUNDHEIT tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 The COVID19 pandemic has shown our health care fragility vis a vis novel pathogens, with a global disruption on societal welfare. Despite th...
2022-05-20 - 2027-08-31 | Financiado
SEMACRET: Sustainable exploration for orthomagmatic (critical) raw materials in the EU: Charting the road to t... OULUN YLIOPISTO tramitó un HORIZON EUROPE: HORIZON-CL4-2021-RESILIENCE-01 Critical raw materials (CRMs) are fundamental to the EU industrial value chains and strategic sectors, particularly with regard to the green...
2022-05-20 - 2025-05-31 | Financiado
UNDINE: The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infect... AARHUS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "The consequences of SARS-CoV-2 exposure range from a lack of infection to lethal COVID-19. This immense inter-individual clinical variabili...
2022-05-20 - 2026-05-31 | Financiado
MyPath: Developing and implementing innovative Patient Centred Care Pathways for cancer patients Innovasjon Norge tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 In the EU, 2.7M people were diagnosed with and 1.3M died of cancer in 2020. Over 12M people have survived cancer, thanks to advances in earl...
2022-05-20 - 2027-08-31 | Financiado
EuReComp: European recycling and circularity in large composite components ETHNICON METSOVION POLYTECHNION tramitó un HORIZON EUROPE: HORIZON-CL4-2021-RESILIENCE-01 EUReCOMP aims to provide sustainable methods towards recycling and reuse of composite materials, coming from components used in various indu...
2022-05-20 - 2026-03-31 | Financiado
GENEGUT: Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 Crohn’s disease is a non-communicable, global disease with an accelerating incidence (up to 23 per 100,000 persons/year) and annual health c...
2022-05-19 - 2026-09-30 | Financiado
SINPAIN: A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to tr... FUNDACION CIDETEC tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 According to the WHO Osteoarthritis (OA) is one major course of years lived with disability in the elderly and considered a high burden dise...
2022-05-19 - 2026-10-31 | Financiado
CANCERNA: RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY HADASSAH MEDICAL ORGANIZATION tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 In the past five years, RNA therapeutics have witnessed a true revolution. Several RNA-based therapies have been approved for the treatment...
2022-05-19 - 2025-05-31 | Financiado
PAL-CYCLES: PALliative Care Yields Cancer welLbEing Support STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Challenge: many patients with advanced cancer in the final phase of life leave the hospital without continuity of information, and certainty...
2022-05-18 - 2027-08-31 | Financiado
4.UNCAN.eu: A Coordination and Support Action to prepare UNCAN.eu platform INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-MISS-2021-UNCAN-01 The 15-month coordination and support action 4.UNCAN.eu will generate a strategic agenda to launch UNCAN.eu, a European initiative to UNders...
2022-05-17 - 2023-11-30 | Financiado
MC4: Multi-level Circular Process Chain for Carbon and Glass Fibre Composites PROFACTOR GMBH tramitó un HORIZON EUROPE: HORIZON-CL4-2021-RESILIENCE-01 Each year about 110.000t of carbon fibre composite parts and 4.500.000t of glass fibre composites are used. 98% of these parts end up in lan...
2022-05-16 - 2025-03-31 | Financiado